Searched for
PANACEA BIOTEC SHARES
Panacea Biotec shares rally 5% as co gets UNICEF supply order worth Rs 127 crorePanacea Biotec's shares rose 5% as the company received a Letter of Award from UNICEF for supplying 115 million doses of its bivalent oral ...- Panacea Biotec zooms 20% on Rs 1,040-crore order win from UNICEF and PAHOPentavalent vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections cau...
- Panacea Biotec hits 5% upper circuit after Mankind Pharma dealAs part of this arrangement, Mankind Pharma is retaining Panacea's sales and marketing team engaged in the particular business.
- Panacea Biotec posts loss of Rs 54 cr in Q4Shares of Panacea Biotec closed at Rs 415.30 per scrip on BSE, up 0.12 percent from its previous close.
- Panacea Biotec soars 5% as production of Sputnik V kicks offShares of Panacea Biotec have delivered 190 per cent return in the last one year, soaring from Rs 141.5 to Rs 407.2. The counter has more t...
- Adar Poonawalla transfers entire Panacea Biotec stake worth Rs 118 cr to Serum InstitutePoonawalla sold 3.15 million shares of Panacea Biotech at Rs 373.85 per share to Serum Institute in a block deal on the BSE earlier today.
- Panacea Biotec soars 17% after company signs deal to produce Sputnik V vaccine dosesProduction of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF, a joint ...
- Panacea Biotec shares zoom 20% on collaboration with US-based Refana to develop COVID-19 vaccineThe collaboration aims to bring to patients a whole inactivated virus-based vaccine for COVID-19, it added.
- Panacea Biotec tanks 6% after CARE downgrades firmCurrently, the m-cap of the company stands at Rs 1,508.61 crore.
- Panacea Biotec gets USFDA nod to launch Prasugrel tabletsThe product has been launched in the market by Apotex Corp, which is the exclusive sales and distribution partner for this product in US, P...
- Panacea launches prostate cancer drugDrug firm Panacea Biotec today launched Cabapan injection, an indigenously developed drug for treating prostate cancer.
- Panacea Biotec enters into collaboration for generic productPanacea Biotec said it has entered into a collaboration with an international pharmaceutical company for development and supply of a generi...
- Panacea enters into alliance with Canada based Apotex IncCommenting on the development, Panacea Biotec Joint MD Rajesh Jain said: "This strategic alliance with Apotex is one of the cardinal milest...
- Panacea Biotec Q3 net profit at Rs 83 crorePanacea Biotec today posted a net profit of Rs 82.79 crore for the third quarter ended December 31, 2013.
- Serum Institute buys 3 lakh shares of Panacea for Rs 3.7 crVaccine firm Serum Institute of India today purchased about three lakh shares of Panacea Biotec for Rs 3.71 crore through open market trans...
- Buy Panacea Biotec Ltd with a target of Rs 125: Sandeep WaglePanacea Biotec Ltd is a ‘buy’ call with a stop loss of Rs 113.5.
- Serum Institute hikes stake in Panacea Biotec to 7%India’s largest vaccine maker, Serum Institute of India, has picked up close to 7% stake in rival firm Panacea Biotec.
- Panacea to buy 19.9% in PharmAthene for $13.1 mnVaccine maker Panacea Biotec has agreed to buy 19.9% in US-based PharmAthene for $13.1 mn.
- Panacea enters into alliance with US-based PharmAtheneVaccine manufacturer Panacea Biotec on Wednesday said it has entered into a strategic alliance with US-based PharmAthene and will invest 13...
- Panacea pre-qualified by WHO for combination vaccinesPanacea Biotec has been pre-qualified by WHO for supplying innovative combination vaccines for pediatric immunization-EasyFour (DTP + Hib) ...
Load More
